Patent · US Active

Compositions and methods to treat cancer

US11530413B2 · kind B2 · utility

2Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2018
Grant dateDec 20, 2022
Priority date
Expiry dateJul 20, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The disclosure provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating patients having cancer, wherein the cancer is amenable to therapeutic treatment with an inhibitor, e.g., an inhibitor of any of the targets disclosed herein. Kits, methods of screening for candidate inhibitors, and associated methods of treatment are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.